Matinas BioPharma Holdings (MTNB) EBIT Margin (2015 - 2023)
Matinas BioPharma Holdings' EBIT Margin was -2168.43% in FY2023, down 1397.10 percentage points from -771.33% in FY2022.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) EBIT Margin (2015 - 2023) Analysis & Trends
From FY2015 onward, Matinas BioPharma Holdings has reported EBIT Margin for 8 years.
- EBIT Margin shows a five-year change of +10062.50 percentage points (FY2018 to FY2023).
- Annual EBIT Margin has moved between -74954.55% (FY2021) and -771.33% (FY2022) over five years.
- Per Business Quant data, EBIT Margin in earlier years was -771.33% in FY2022 (+74183.22 pp), -74954.55% in FY2021 (-59666.16 pp), -15288.38% in FY2020 (+5779.00 pp) and -21067.38% in FY2019 (-8836.45 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Matinas BioPharma Holdings | 679,055.62 | -11.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -509.67% |
| Dec 31, 2022 | -515.52% |
| Sep 30, 2022 | -513.83% |
| Jun 30, 2022 | -557.38% |
| Mar 31, 2021 | -19,059.52% |
| Dec 31, 2020 | -10,382.22% |
| Sep 30, 2020 | -5,848.30% |
| Jun 30, 2019 | -5,033.49% |
| Jun 30, 2018 | -3,791.13% |
| Mar 31, 2018 | -13,764.74% |
| Dec 31, 2017 | -10,311.72% |
| Sep 30, 2017 | -7,589.85% |
| Jun 30, 2017 | -8,854.73% |
| Mar 31, 2017 | -29,976.78% |
| Sep 30, 2015 | -3,606.48% |
| Jun 30, 2015 | -3,119.21% |
| Mar 31, 2015 | -4,456.62% |
API Access
Matinas BioPharma Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();